Suspension-Vero cell cultures as a platform for viral vaccine production

Vaccine

Volumn 27, Issue 46, 2009, Pages 6464-6467

  Paillet, Cristian ^c   Forno, Guillermina ^a,c   Kratje, Ricardo ^a,b   Etcheverrigaray, Marina ^a,b  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^c Zelltek SA   (Argentina)

Author keywords

Suspension culture; Vaccines; Vero cells

Indexed keywords

AMMONIA; GLUCOSE; LACTIC ACID; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; BIOREACTOR; CELL DENSITY; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; HERPES SIMPLEX VIRUS 1; NONHUMAN; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; PRODUCTIVITY; VACCINE PRODUCTION; VERO CELL; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; BIOREACTORS; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; CULTURE MEDIA, SERUM-FREE; HERPESVIRUS 1, HUMAN; POLIOVIRUS; VERO CELLS; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL VACCINES; VIRUS CULTIVATION;

EID: 70350154349     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.020     Document Type: Article

References (13)

1. cip1 in adaptation of CHO cell to suspension and protein-free culture. J Biotechnol 130 (2007) 282-290
2. Frazzati-Gallina N.M., Paoli R.L., Mourão-Fuches R.M., Jorge S.A.C., and Pereira C.A. Higher production of rabies virus in serum-free media cell cultures on microcarriers. J Biotechnol 92 (2001) 67-72
3. Gregersen J.P. A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine. Vaccine 26 (2008) 3332-3340
4. World Health Organization. Requirements for the use of animal cells as in vitro substrates for the production of biologicals. WHO Technical Report Series vol. 878 (1998), WHO, Geneva p.20-53 [Annex 1].
5. Montagnon B.J., Vincent-Falquet J.C., and Fanget B. Thousand liter scale microcarrier culture of Vero cells for killed polio virus vaccine. Dev Biol Stand 55 (1984) 37-42
6. Wu S.C., Liu C.C., and Lian W.C. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22 (2004) 3858-3864
7. Choi Y., Ahn C.J., Seong K.M., Jung M.Y., and Ahn B.Y. Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. Vaccine 21 (2003) 1867-1873
8. Litwin J. The growth of Vero cells in suspension as cell-aggregates in serum-free media. Cytotechnology 10 (1992) 169-174
9. Butler M., Burgener A., Patrick M., Berry M., Moffatt D., Huzel N., et al. Application of a serum-free media for the growth of Vero cells and the production of reovirus. Biotechnol Prog 16 (2000) 854-858
10. Rourou S., Ark A., Velden T., and Kallel H. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 25 (2007) 3879-3889
11. Mendoça R.Z., Arrózio S.J., Antoniazzi M.M., Ferreira J.M.C., and Pereira C.A. Metabolic active-high density Vero cell cultures on microcarriers following apoptosis prevention by galactose/glutamine feeding. J Biotechnol 97 (2002) 13-22
12. Trabelsi K., Rourou S., Lukil H., Majoul S., and Kallel H. Comparison of various culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor. Enzyme Microb Technol 36 (2005) 514-519
13. Nadeau I., and Kamen A. Production of adenovirus vector for gene therapy. Biotechnol Adv 20 (2003) 475-489